In with the new: the determinants of prescribing innovation by general practitioners in Ireland

European Journal of Health Economics

Volumn 13, Issue 4, 2012, Pages 393-407

  Bourke, Jane ^a,b   Roper, Stephen ^b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Equilibrium and nonequilibrium models of adoption; General practitioners; Ireland; Prescribing innovation

Indexed keywords

ARTICLE; EQUILIBRIUM CONSTANT; GENERAL PRACTITIONER; HUMAN; IRELAND; MEDICAL PRACTICE; PRESCRIPTION; PRIORITY JOURNAL; RURAL AREA;

EID: 85027952857     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-011-0311-5     Document Type: Article

References (48)

1. Prosser, H., Almond, S., Walley, T.: Influences on GPs' decision to prescribe new drugs -the importance of who says what. Family Pract. 20, 61-68 (2009)
2. Thistlehwaite, J.E., Ajjawi, R., Aslani, P.: The decision to prescribe: Influences and choice. InnovAiT 3(4), 237-243 (2010)
3. Jones, M.I., Greenfield, S.M., Bradley, C.P.: Prescribing new drugs: Qualitative study of influences on consultants and general practitioners. BMJ 323(7309), 378 (2001)
4. Rogers, E.M.: Diffusion of Innovations, 5th edn. Free Press, New York (2003)
5. Layte, R., et al.: Projecting the impact of demographic change on the demand for and delivery of health care in Ireland. In: Layte, R. (ed). ESRI, Dublin (2009)
6. Wren, M.-A.: Unhealthy State: Anatomy of a Sick Society. New Island, Dublin (2003)
7. Ireland: Primary Care: A New Direction. Government of Ireland, Dublin (2001)
8. Competition Authority: Competition in Professional Services. General Medical Practitioners. Competition Authority, Dublin (2009)
9. Thomas, S., Normand, C., Smith, S.: Social Health Insurance: Further Options for Ireland, pp. 1-45. Trinity College Dublin, Dublin (2008)
10. Carlsen, B., Glenton, C., Pope, C.: Thou shalt versus thou shalt not: A meta-analysis of GPs' attitudes to clinical practice guidelines. Br. J. Gen. Pract. 57, 971-978 (2007)
11. Mason, A.: New medicines in primary care: A review of influences on general practitioner prescribing. J. Clin. Pharm. Ther. 33, 1-10 (2008)
12. Wathen, B., Dean, T.: An evaluation of the impact of NICE guidance on GP prescribing. Br. J. Gen. Pract. 54, 103-107 (2004) (Pubitemid 38190231)
13. Karshenas, M., Stoneman, P.L.: Rank, Stock, Order, and epidemic effects in the diffusion of new process technologies: An empirical model. RAND J. Econ. 24(4), 503-528 (1993)
14. Baptista, R.: Do innovations diffuse faster within geographical clusters? Int. J. Ind. Organization 18(3), 515-535 (2000)
15. Schumpeter, J.A.: Capitalism, Socialism and Democracy. Harper and Brothers, New York (1942)
16. Hall, B.: Innovation and diffusion. In: Fagerberg, J., Mowery, D., Nelson, R.R. (eds.) Handbook of Innovation. Oxford University Press, Oxford (2004)
17. Battisti, G., et al.: Inter and intra firm diffusion of ICT in the United Kingdom (UK) and Switzerland (CH): An internationally comparative study base on firm-level data. Econ. Innovation New Technol. 16(8), 669-687 (2007)
18. McWilliams, B., Zilbermanfr, D.: Time of technology adoption and learning by using. Econ. Innovation New Technol. 4(2), 139-154 (1996)
19. Rosenberg, N.: Inside the Black Box: Technology and Economics. Cambridge University Press, Cambridge (1982)
20. Stoneman, P., Kwon, M.-J.: The diffusion of multiple process technologies. Econ. J. 104(423), 420-431 (1994) (Pubitemid 24390976)
21. Colombo, M.G., Mosconi, R.: Complementarity and cumulative learning effects in the early diffusion of multiple technologies. J. Ind. Econ. 43(1), 13-48 (1995)
22. Stoneman, P., Toivanen, O.: The diffusion of multiple technologies: An empirical study. Econ. Innovation New Technol. 5(1), 1-17 (1997)
23. Arvantis, S., Hollenstein, H.: The determinants of the adoption of advanced manufacturing technology. Econ. Innovation New Technol. 10, 377-414 (2001)
24. Coleman, J., Katz, E., Menzel, H.: Medical Innovation: A Diffusion Study. Bobbs Merrill, New York (1966)
25. Kozyrskyj, A., Raymond, C., Racher, A.: Characterizing early prescribers of newly marketed drugs in Canada: A populationbased study. Eur. J. Clin. Pharmacol. 63, 597-604 (2007) (Pubitemid 46684483)
26. Williamson, P.M.: The adoption of new drugs by doctors practising in group and Solo practice. Social Sci. Med. 9, 233-236 (1975)
27. Steffensen, F.H., Toft Sorensen, H., Olesen, F.: Diffusion of new drugs in Danish general practice. Family Pract. 16(4), 407-413 (1999) (Pubitemid 29410763)
28. Tamblyn, R., et al.: Physician and practice characteristics associated with the early utilisation of new prescription drugs. Med. Care 41(8), 895-908 (2003)
29. Dybdahl, T., et al.: Does the early adopter of drugs exist? a population-based study of general practitioners' prescribing of new drugs. Eur. J. Clin. Pharmacol. 60, 667-672 (2004) (Pubitemid 40064600)
30. Florentinus, S.R.: New drugs in general practice: Prescribing patterns and external influences. In: Utrecht Institute for Pharamacutical Devices, Utrecht (2006)
31. O'Dowd, T., O'Kelly, M., O'Kelly, F.: Structure of general practice in Ireland, 1982-2005. Irish College of General Practitioners and Trinity College Dublin, Dublin (2006)
32. Scott, A.: Economics of general practice. In: Anthony, J.C.J. (ed.
33. Handbook of Health Economic. Elsevier (2000)
34. Kann, I.C., Biorn, E., Luras, H.: Competition in general practice: Prescriptions to the elderly in a list patient system. J. Health Econ. 29, 751-764 (2010)
35. Dybdahl, T., et al.: General practitioners' adoption of new drugs and previous prescribing of drugs belonging to the same therapeutic class: A pharmacoepidemiological study. Br. J. Clin. Pharmacol. 60(5), 526-533 (2005) (Pubitemid 41532453)
36. Baptista, R.: The diffusion of process innovations: A selective review. Int. J. Econ. Bus. 6(1), 107-129 (1999)
37. Battisti, G., Stoneman, P.: The intra-firm diffusion of new process technologies. Int. J. Ind. Organization 23(1-2), 1-22 (2005) (Pubitemid 40467314)
38. Hollenstein, H., Woerter, M.: The decision to adopt internetbased E-commerce. An empirical analysis based on swiss firmlevel data. In: KOF Working Paper. Zurich (2004)
39. Burton, M., Rigby, D., Young, T.: Modelling the adoption of organic horticulture technology in the UK using duration analysis. Aust J. Agricultual Resour. Econ. 47(1), 29-54 (2003) (Pubitemid 36435195)
40. Leahy, A., Wiley, M.: The Irish Health System in the 21st Century. Oak Tree Press, Dublin (1998)
41. Barry, M., et al.: Projecting the impact of demographic change on the demand for and delivery of health care in Ireland. In: Layte, R. (ed.) p. 178. Economic and Social Research Institute, Dublin (2009)
42. Jenkins, S.P.: Lessons on survival analysis. Available from. http://www.iser.essex.ac.uk/study/resources/module-ec968 (2005)
43. Greene, W.H.: Econometric Analysis, 5th edn. Prentice Hall, New Jersey (2003)
44. Kiefer, N.M.: Economic duration data and hazard functions. J. Eco. Literature 26(2), 646-679 (1988)
45. Jenkins, S.P.: Survival analysis. In: Unpublished Lecture Notes (2003)
46. StataCorp: Stata Statistical Software: Release 11. StataCorp LP, College Station, TX (2009)
47. Masters, K.: For what purpose and reasons do doctors use the internet: A systematic review. Int. J. Med. Informatics 77(1), 4-16 (2008) (Pubitemid 350161420)
48. Meade, B., Buckley, D., Boland, M.: What factors affect the use of electronic patient records by Irish GPs? Int. J. Med. Informatics 78(8), 551-558 (2009)